CTLA4 and cancer: We could not confirm any correlation between CTLA-4+ cell number and prognosis, as recently reported in 40 adult cHL cases by Pangaribuan et al., who showed its association with IPS adverse prognostic factors in cases of advanced-stage cHL, suggesting that immune checkpoints might be involved in cancer progression [27].